{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:21:21Z","timestamp":1787678481204,"version":"build-2784847793"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007613","name":"Ankara Universitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018719","name":"Ko\u00e7 \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018719","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110197","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:26:01Z","timestamp":1782923161000},"page":"110197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis and biological evaluation of 6,9-disubstituted purine analogues inducing autophagy-mediated apoptosis and potentiating carboplatin response in high-grade serous ovarian cancer"],"prefix":"10.1016","volume":"180","author":[{"given":"P\u0131nar","family":"Kul Karadenizli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deren","family":"Demirel Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Alt\u0131parmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Yilmaz Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idil Su","family":"Canitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Tuncbilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem","family":"Durmaz Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110197_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.564601","article-title":"PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance","volume":"8","author":"Rose","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110197_bb0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110197_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medicina56010015","article-title":"Tumor microenvironment","volume":"56","author":"Arneth","year":"2020","journal-title":"Medicina"},{"key":"10.1016\/j.bioorg.2026.110197_bb0020","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3389\/fimmu.2018.01697","article-title":"Potential mechanisms connecting purine metabolism and Cancer therapy","volume":"9","author":"Yin","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110197_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/17568919.2025.2594966","article-title":"Purine derivatives as potent anticancer agents: a comprehensive review","volume":"18","author":"Farooqui","year":"2026","journal-title":"Future Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110197_bb0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/cells13040345","article-title":"Complexity of the genetic background of oncogenesis in ovarian Cancer\u2014genetic instability and clinical implications","volume":"13","author":"Murawski","year":"2024","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110197_bb0035","first-page":"436","article-title":"Transforming treatment paradigms: focus on personalized medicine for high-grade serous ovarian cancer","volume":"75","author":"Kordowitzki","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110197_bb0040","doi-asserted-by":"crossref","unstructured":"J.M. Liberto, S.-Y. Chen, I.-M. Shih, T.-H Wang, T.-L. Wang, T.R. Pisanic, 2022. Current and emerging methods for ovarian Cancer screening and diagnostics: a comprehensive review. Cancers, 14(12), 2885. doi:https:\/\/doi.org\/10.3390\/cancers14122885.","DOI":"10.3390\/cancers14122885"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110197_bb0050","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174013","article-title":"Biology-driven therapy advances in high-grade serous ovarian cancer","volume":"134","author":"Wang","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110197_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13048-021-00908-8","article-title":"The prognostic factor for recurrence in advanced-stage high-grade serous ovarian cancer after complete clinical remission: a nested case-control study","volume":"14","author":"Wang","year":"2021","journal-title":"J. Ovarian Res."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110197_bb0060","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110197_bb0045","article-title":"Unveiling drug resistance pathways in high-grade serous ovarian cancer(HGSOC): recent advances and future perspectives","volume":"16","author":"Fu","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110197_bb0065","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/AOG.0b013e318264f794","article-title":"Ten-year relative survival for epithelial ovarian cancer","volume":"120","author":"Baldwin","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.bioorg.2026.110197_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx441","article-title":"Treatment of recurrent ovarian cancer","volume":"28","author":"Pignata","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bioorg.2026.110197_bb0075","article-title":"Targeted therapy in high grade serous ovarian Cancer: a literature review","volume":"54","author":"Dinkins","year":"2024","journal-title":"Gynecol Oncol Reports"},{"issue":"26","key":"10.1016\/j.bioorg.2026.110197_bb0080","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance Olaparib in patients with newly diagnosed advanced ovarian Cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.110197_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.134967","article-title":"Targeting cancer through recently developed purine clubbed heterocyclic scaffolds: An overview","volume":"1280","author":"Chaurasiya","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"27","key":"10.1016\/j.bioorg.2026.110197_bb0095","doi-asserted-by":"crossref","first-page":"21604","DOI":"10.1039\/D5RA02893K","article-title":"From molecule to medicine: introducing emerging strategies to synthesize potent anticancer purine scaffolds","volume":"15","author":"Hashmi","year":"2025","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110197_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ctrv.2006.05.002","article-title":"Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis","volume":"32","author":"Steurer","year":"2006","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bioorg.2026.110197_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13048-022-01022-z","article-title":"Targeting purine metabolism in ovarian cancer","volume":"15","author":"Liu","year":"2022","journal-title":"J. Ovarian Res."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110197_bb0110","first-page":"2872","article-title":"Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine","volume":"35","author":"Nelson","year":"1975","journal-title":"Canser Res."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110197_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2015.01.010","article-title":"The purine analog fludarabine acts as a cytosolic 5\u2032-nucleotidase II inhibitor","volume":"94","author":"Cividini","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110197_bb0120","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1517\/13543780903071038","article-title":"Cladribine: not just another purine analogue?","volume":"18","author":"Spurgeon","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bioorg.2026.110197_bb0125","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/cancers15092485","article-title":"The role of STATs in ovarian Cancer: exploring their potential for therapy","volume":"15","author":"Standing","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110197_bb0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41416-019-0674-4","article-title":"Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours","volume":"122","author":"Roberts","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110197_bb0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5530\/jyp.20251471","article-title":"The impact of novel purine, pyrimidine and folate analogues on cancer treatment: a review","volume":"17","author":"Ramakrishna","year":"2025","journal-title":"J. Young Pharm."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110197_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30132707","article-title":"Hybrid molecules with purine and pyrimidine derivatives for antitumor therapy: news, perspectives, and future directions","volume":"30","author":"Iacob (Ciobotaru)","year":"2025","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110197_bb0145","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2003.04.031","article-title":"Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers","volume":"21","author":"Kantarjian","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.110197_bb0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.cdd.4402257","article-title":"R-Roscovitine simultaneously targets both the p53 and NF-KB pathways and causes potentiation of apoptosis: implications in cancer therapy","volume":"15","author":"Dey","year":"2008","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110197_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108371","article-title":"MCL1 and BCL-xL levels in solid tumors are predictive of dinaciclib-induced apoptosis","volume":"9","author":"Booher","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110197_bb0160","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/med.21856","article-title":"Analyzing the scaffold diversity of cyclin-dependent kinase inhibitors and revisiting the clinical and preclinical pipeline","volume":"42","author":"Bhurta","year":"2022","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110197_bb0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/1074248410370327","article-title":"Autophagy: definition, molecular machinery, and potential role in myocardial ischemia-reperfusion injury","volume":"15","author":"Dong","year":"2010","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110197_bb0170","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.biocel.2004.04.011","article-title":"Apoptosis, autophagy, and more","volume":"36","author":"Lockshin","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110197_bb0175","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.15252\/embj.201796697","article-title":"Molecular definitions of autophagy and related processes","volume":"36","author":"Galluzzi","year":"2017","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110197_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14030339","article-title":"The interplay between autophagy and apoptosis in the mechanisms of action of stilbenes in Cancer cells","volume":"14","author":"Siedlecka-Kroplewska","year":"2025","journal-title":"Antioxidants"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110197_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100871","article-title":"The interaction mechanism between autophagy and apoptosis in colon cancer","volume":"13","author":"Xie","year":"2020","journal-title":"Transl. Oncol."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110197_bb0190","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1002\/jcp.25785","article-title":"Crosstalk of autophagy and apoptosis: involvement of the dual role of autophagy under ER stress","volume":"232","author":"Song","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110197_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10495-007-0154-9","article-title":"Apoptosis and autophagy: regulatory connections between two supposedly different processes","volume":"13","author":"Thorburn","year":"2008","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2026.110197_bb0200","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/317645","article-title":"Novel insights into the interplay between apoptosis and autophagy","volume":"2012","author":"Rikiishi","year":"2012","journal-title":"Int J Cell Biol"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110197_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.110197_bb0210","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fphar.2020.00408","article-title":"Combination of an autophagy inducer and an autophagy inhibitor: a smarter strategy emerging in Cancer therapy","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110197_bb0215","first-page":"40","article-title":"Therapeutic implications for ovarian cancer emerging from the tumor Cancer genome atlas","volume":"4","author":"Verschraegen","year":"2015","journal-title":"Transl. Cancer Res."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110197_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121983","article-title":"p53-mediated tumor suppression: DNA-damage response and alternative mechanisms","volume":"11","author":"Pitolli","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110197_bb0225","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1634\/theoncologist.2012-0028","article-title":"BRCAness: finding the Achilles heel in ovarian Cancer","volume":"17","author":"Rigakos","year":"2012","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110197_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13081004","article-title":"Sodium selenite induces autophagy and apoptosis in cervical Cancer cells via mitochondrial ROS-activated AMPK\/mTOR\/FOXO3a pathway","volume":"13","author":"Lv","year":"2024","journal-title":"Antioxidants"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110197_bb0235","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3390\/nu14122413","article-title":"Resveratrol induces autophagy and apoptosis in non-small-cell lung Cancer cells by activating the NGFR-AMPK-mTOR pathway","volume":"14","author":"Li","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bioorg.2026.110197_bb0240","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejmech.2014.10.080","article-title":"Synthesis of novel substituted purine derivatives and identification of the cell death mechanism","volume":"89","author":"Demir","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110197_bb0245","first-page":"2658","article-title":"Newly synthesized 6-substituted piperazine\/phenyl-9-cyclopentyl containing purine nucleobase analogs act as potent anticancer agents and induce apoptosis via inhibiting Src in hepatocellular carcinoma cells, RSC","volume":"14","author":"Bilget Guven","year":"2023","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110197_bb0250","article-title":"Synthesis and cytotoxicity of novel 6,8,9-trisubstituted purine analogs against liver cancer cells","volume":"106","author":"Polat","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110197_bb0255","doi-asserted-by":"crossref","first-page":"108","DOI":"10.55730\/1300-0527.3643","article-title":"Exploration of novel 6,8,9-trisubstituted purine analogues: synthesis, in vitro biological evaluation, and their effect on human cancer cells","volume":"48","author":"Polat","year":"2023","journal-title":"Turk. J. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110197_bb0260","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1021\/jm3001532","article-title":"Synthesis of novel 6-(4-substituted piperazine-1-yl)-9-(\u03b2-D-ribofuranosyl)purine derivatives, which lead to senescence-induced cell death in liver cancer cells","volume":"55","author":"Tuncbilek","year":"2012","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110197_bb0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bmcl.2017.12.070","article-title":"Synthesis of novel 6-substituted amino-9-(\u03b2-d-ribofuranosyl)purine analogs and their bioactivities on human epithelial cancer cells","volume":"28","author":"Tuncbilek","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110197_bb0270","doi-asserted-by":"crossref","first-page":"70","DOI":"10.17344\/acsi.2019.5196","article-title":"Synthesis and in vitro cytotoxic activity of new 6,9-Disubstituted purine analogues","volume":"67","author":"Kucukdumlu","year":"2020","journal-title":"Acta Chim. Slov."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110197_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202200328","article-title":"A perspective study on the RTK, PI3K, B-Raf, CDK and the multi-protein targeting in medicinal chemistry","volume":"19","author":"Mohamed","year":"2022","journal-title":"Chem. Biodivers."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110197_bb0280","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.bmc.2008.12.050","article-title":"Synthesis and antimicrobial evaluation of some new substituted purine derivatives","volume":"17","author":"Tun\u00e7bilek","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110197_bb0285","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/27694127.2022.2047266","article-title":"SRC plays a specific role in the cross-talk between apoptosis and autophagy via phosphorylation of a novel regulatory site on AMPK","volume":"1","author":"Zhao","year":"2022","journal-title":"Autophagy Reports."},{"key":"10.1016\/j.bioorg.2026.110197_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117585","article-title":"Physiological and tumor-associated angiogenesis: key factors and therapy targeting VEGF\/VEGFR pathway","volume":"180","author":"Lorenc","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110197_bb0295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4161\/auto.3424","article-title":"Control of the autophagy maturation step by the MAPK ERK and p38: lessons from environmental carcinogens","volume":"3","author":"Corcelle","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.bioorg.2026.110197_bb0300","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41419-023-06272-3","article-title":"Inhibition of PDGFR\u03b2 alleviates endothelial cell apoptotic injury caused by DRP-1 overexpression and mitochondria fusion failure after mitophagy","volume":"14","author":"An","year":"2023","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110197_bb0305","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00018-023-04859-9","article-title":"Autophagy protein 5 controls flow-dependent endothelial functions","volume":"80","author":"Nivoit","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110197_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102509","article-title":"Erk: a double-edged sword in cancer. Erk-dependent apoptosis as a potential therapeutic strategy for cancer","volume":"10","author":"Sugiura","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110197_bb0320","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3892\/ol.2020.11684","article-title":"Dual effects of active erk in cancer: a potential target for enhancing radiosensitivity (review)","volume":"20","author":"Lu","year":"2020","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110197_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054044","article-title":"Purine nucleoside analog - Sulfinosine modulates diverse mechanisms of Cancer progression in multi-drug resistant Cancer cell lines","volume":"8","author":"Da\u010devi\u0107","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110197_bb0330","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1080\/15548627.2019.1582951","article-title":"A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy","volume":"15","author":"Chang","year":"2019","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110197_bb0335","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrm3735","article-title":"Self-consumption: the interplay of autophagy and apoptosis","volume":"15","author":"Mari\u00f1o","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110197_bb0340","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/cdd.2009.33","article-title":"Life and death partners: apoptosis, autophagy and the cross-talk between them","volume":"16","author":"Eisenberg-Lerner","year":"2009","journal-title":"Cell Death Differ."},{"issue":"41","key":"10.1016\/j.bioorg.2026.110197_bb0345","doi-asserted-by":"crossref","first-page":"30373","DOI":"10.1074\/jbc.M602097200","article-title":"NF-\u03baB activation represses tumor necrosis factor-\u03b1-induced autophagy","volume":"281","author":"Djavaheri-Mergny","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110197_bb0350","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.biopha.2012.08.001","article-title":"Autophagy induction of reversine on human follicular thyroid cancer cells","volume":"66","author":"Lu","year":"2012","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110197_bb0355","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.3892\/mmr.2015.3906","article-title":"Purine analogue ENERGI-F706 induces apoptosis of 786-O renal carcinoma cells via 5\u2032-adenosine monophosphate-activated protein kinase activation","volume":"12","author":"Hsu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2026.110197_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.155","article-title":"BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells","volume":"4","author":"Sharma","year":"2013","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110197_bb0365","first-page":"3413","article-title":"Triptolide induces autophagy and apoptosis through ERK activation in human breast cancer MCF-7 cells","volume":"15","author":"Gao","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bioorg.2026.110197_bb0370","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12935-018-0692-y","article-title":"ERK-mediated autophagy promotes inactivated Sendai virus (HVJ-E)-induced apoptosis in HeLa cells in an Atg3-dependent manner","volume":"18","author":"Wang","year":"2018","journal-title":"Cancer Cell Int."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110197_bb0375","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s10495-013-0867-x","article-title":"Estradiol inhibits osteoblast apoptosis via promotion of autophagy through the ER-ERK-mTOR pathway","volume":"18","author":"Yang","year":"2013","journal-title":"Apoptosis"},{"issue":"32","key":"10.1016\/j.bioorg.2026.110197_bb0380","doi-asserted-by":"crossref","first-page":"21412","DOI":"10.1074\/jbc.M109.026013","article-title":"A non-canonical MEK\/ERK signaling pathway regulates autophagy via regulating Beclin 1","volume":"284","author":"Wang","year":"2009","journal-title":"J. Biol. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:31:56Z","timestamp":1787675516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826007339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":74,"alternative-id":["S0045206826007339"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110197","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of 6,9-disubstituted purine analogues inducing autophagy-mediated apoptosis and potentiating carboplatin response in high-grade serous ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110197"}}